Literature DB >> 12439148

Central retinal vein occlusion and thrombophilia risk factors.

Y P Adamczuk1, M L Iglesias Varela, M E Martinuzzo, G S Cerrato, R R Forastiero.   

Abstract

The purpose of the present study was to investigate the role of risk factors predisposing to thrombosis in patients with central retinal vein occlusion (CRVO). We prospectively examined 37 consecutive patients with CRVO, and 144 healthy controls, for major and potential inherited and acquired thrombophilic risk factors. Among them, only the prevalence of hyperhomocysteinaemia (10/37, 27.0%) and antiphospholipid antibodies positivity (5/37, 13.5%) were significantly higher in patients with respect to controls (5.5%, P < 0.001 and 2.1%, P < 0.01, respectively). Both hyperhomocysteinaemia and antiphospholipid antibodies seem to be associated with CRVO. A search for acquired thrombophilia is advisable in patients with CRVO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439148     DOI: 10.1097/00001721-200210000-00007

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria.

Authors:  Marc Sorigue; Jordi Juncà; Elisa Orna; Nevena Romanic; Edurne Sarrate; Jordi Castellvi; Montse Soler; Ines Rodríguez-Hernandez; Evarist Feliu; Susana Ruiz
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

2.  Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings.

Authors:  Donatella Colaizzo; Lucio Amitrano; Luigi Iannaccone; Patrizia Vergura; Filomena Cappucci; Elvira Grandone; Maria Anna Guardascione; Maurizio Margaglione
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

Review 3.  [Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies].

Authors:  M Rehak; M Müller; M Scholz; J Wiercinska; D Niederwieser; P Wiedemann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

4.  Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

5.  A longitudinal analysis of risk factors associated with central retinal vein occlusion.

Authors:  Maxwell S Stem; Nidhi Talwar; Grant M Comer; Joshua D Stein
Journal:  Ophthalmology       Date:  2012-11-20       Impact factor: 12.079

Review 6.  Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.

Authors:  Dan Li; Minwen Zhou; Xiaoyan Peng; Huiyu Sun
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

7.  Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis.

Authors:  Yuanyuan Zou; Xi Zhang; Jingyi Zhang; Xiangning Ji; Yuqing Liu
Journal:  Oncotarget       Date:  2017-09-04

Review 8.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424

Review 9.  Antiphospholipid antibody and risk of retinal vein occlusion: a systematic review and meta-analysis.

Authors:  Wei Zhu; Yan Wu; Ming Xu; Jin-Yu Wang; Yi-Fang Meng; Zheng Gu; Jiong Lu
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.